The company continues to build validation data and believes its lower cost proposition can help it gain leverage in the European market where molecular tests are not reimbursed.

According to Mikhail Murashko, Russian scientists are developing modern vaccines against tuberculosis, including for preventing the disease in adults and overcoming antibiotic-resistant strains ...

The PCR technologies market is set to grow from USD 14.61 billion in 2024 to USD 21.89 billion by 2030, at a CAGR of 7.0%, driven ...

Diabetes significantly affects daily life, requiring patients to manage multiple medications, frequently monitor glucose ...

It’s good news in the fight against colorectal cancer: A new test can detect the disease with a simple blood draw. But don’t ...

A team of cardiologists shared tips and tricks for clinicians to address the pitfalls they may encounter when conducting ...

POC HBV testing was associated with faster turnaround time for results and higher rates of treatment initiation when compared with standard laboratory-based assays.

NeoGenomics Launches AML Express for Rapid Genetic Profiling of Acute Myeloid Leukemia ...

In a recent article published in the journal Nature Communications, researchers have developed a novel plasmonic biosensor as ...

An article recently published in the journal Scientific Reports introduced a novel method for assessing the severity of ...

Circulating tumor DNA is a promising tool for the detection and surveillance of HPV-positive oropharyngeal squamous cell ...

In a significant advancement for point-of-care medical diagnostics, a team of researchers from UCLA has introduced a deep ...